Sign In
Buy BDX
$145.61
+1.18 (+0.82%)
At Close: Jun 03, 2026
Best 3 Blue Chip Stocks to Buy After a Market Pullback -- Including Microsoft (MSFT) Stock
12:00am, Friday, 29'th May 2026
One of these stocks sports a dividend yield topping 5%.
BD Launches Elyra Thulium Fiber Laser System for Kidney Stone Care
11:16am, Friday, 22'nd May 2026
BDX launches the Elyra Thulium Fiber Laser system to streamline kidney stone care and boost workflow flexibility for urology teams.
BD Delivers Kidney Stone Care for Urology Teams with the Elyra™ Thulium Fiber Laser System
06:50am, Thursday, 21'st May 2026
New laser system is designed to help urology teams enhance efficiency, versatility, and procedural workflow across stone management and soft tissue procedures. FRANKLIN LAKES, N.J.
Peter Menziuso Named EVP and President, BD Interventional
06:50am, Monday, 18'th May 2026
FRANKLIN LAKES, N.J., May 18, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Peter Menziuso has been named execu
AI, Robotics Key to Transforming Health Care: BD CEO
10:36am, Friday, 15'th May 2026
Tom Polen, CEO of medical technology company BD, says that in the next decade AI and robotics will transform health care in ways that will make today's system seem archaic. Polen sits down with Bloomb
Becton, Dickinson and Company (BDX) Presents at Bank of America Global Healthcare Conference 2026 Transcript
05:20pm, Tuesday, 12'th May 2026
Becton, Dickinson and Company (BDX) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Is Becton Dickinson & Co (BDX) a Bargain After 4.2% Drop? GF Value Says Undervalued
08:02pm, Monday, 11'th May 2026
On May 11, 2026, Becton Dickinson and Co (BDX) shares fell 4.2% today, closing at $143.15. This decline continues a downward trend over the past month, where the
Becton, Dickinson and Company Q2 Earnings Call Highlights
10:09am, Saturday, 09'th May 2026
Becton, Dickinson and Company NYSE: BDX reported fiscal second-quarter revenue and adjusted earnings ahead of its internal expectations, while management raised its full-year adjusted earnings outlook
Is the Options Market Predicting a Spike in Becton Dickinson Stock?
04:05pm, Thursday, 07'th May 2026
Investors need to pay close attention to BDX stock based on the movements in the options market lately.
BD Stock Up in Pre-Market Post Q2 Earnings & Revenue Beat, Margins Up
11:35am, Thursday, 07'th May 2026
BDX beats second-quarter fiscal 2026 earnings and revenue estimates, driven by broad segment strength and improved profitability.
Becton, Dickinson and Company (BDX) Q2 2026 Earnings Call Transcript
11:21am, Thursday, 07'th May 2026
Becton, Dickinson and Company (BDX) Q2 2026 Earnings Call Transcript
Here's What Key Metrics Tell Us About Becton Dickinson (BDX) Q2 Earnings
10:31am, Thursday, 07'th May 2026
While the top- and bottom-line numbers for Becton Dickinson (BDX) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics c
Becton Dickinson (BDX) Q2 Earnings and Revenues Surpass Estimates
08:46am, Thursday, 07'th May 2026
Becton Dickinson (BDX) came out with quarterly earnings of $2.9 per share, beating the Zacks Consensus Estimate of $2.77 per share. This compares to earnings of $3.35 per share a year ago.
Becton Dickinson raises annual profit forecast on strength in drug delivery devices
07:57am, Thursday, 07'th May 2026
Becton Dickinson raised its annual profit forecast on Thursday, riding strong demand for its drug-delivery devices and surgical equipment, and appointed Vitor Roque as its chief financial officer.
BD Appoints Vitor Roque Chief Financial Officer
06:31am, Thursday, 07'th May 2026
FRANKLIN LAKES, N.J., May 7, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Vitor Roque has been named executive
